NCT03919071 2026-03-19Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade GliomaNational Cancer Institute (NCI)Phase 2 Active not recruiting58 enrolled
NCT02684058 2023-12-13Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG TumorsNovartisPhase 2 Completed151 enrolled 45 charts 1 FDA